# Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

> **NCT00643890** · PHASE2 · TERMINATED · sponsor: **Neurologix, Inc.** · enrollment: 44 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **GENETIC:** Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus

## Key facts

- **NCT ID:** NCT00643890
- **Lead sponsor:** Neurologix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2010-12
- **Final completion:** —
- **Target enrollment:** 44 (ESTIMATED)
- **Why stopped:** Due to financial reasons
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643890, "Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00643890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*